Table 5. Correlation between serum OSM expression and the AIS prognosis.
n (%) applies to the amount of each outcome and M (Q1, Q3) applies to the respective 90-day mRS score and serum OSM level.
AIS: acute ischemic stroke; OSM: oncostatin M; mRS: modified Rankin scale
Amount (%) | 90-day mRS score | Serum OSM pg/ml | Z-score | P-value | |
Favorable outcome | 79 (58.96%) | 1.00 (0.00, 2.00) | 216.70 (181.70, 258.30) | 0.083 | 0.492 |
Unfavorable outcome | 55 (41,04%) | 4.00 (3.00, 6.00) | 221.98 (181.30, 261.10) |